Connor, Clark & Lunn Investment Management (CC&L)’s iRadimed IRMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $728K | Sell |
12,179
-2,512
| -17% | -$150K | ﹤0.01% | 1146 |
|
|
2025
Q1 | $771K | Sell |
14,691
-1,615
| -10% | -$84.8K | ﹤0.01% | 1035 |
|
|
2024
Q4 | $897K | Buy |
16,306
+2,921
| +22% | +$161K | ﹤0.01% | 977 |
|
|
2024
Q3 | $673K | Buy |
13,385
+4,708
| +54% | +$237K | ﹤0.01% | 1007 |
|
|
2024
Q2 | $381K | Buy |
8,677
+3,743
| +76% | +$164K | ﹤0.01% | 1123 |
|
|
2024
Q1 | $217K | Buy |
4,934
+408
| +9% | +$17.9K | ﹤0.01% | 1378 |
|
|
2023
Q4 | $215K | Sell |
4,526
-2,162
| -32% | -$103K | ﹤0.01% | 1249 |
|
|
2023
Q3 | $297K | Sell |
6,688
-1,665
| -20% | -$73.9K | ﹤0.01% | 1146 |
|
|
2023
Q2 | $399K | Buy |
+8,353
| New | +$399K | ﹤0.01% | 1044 |
|
|
2018
Q4 | – | Sell |
-5,600
| Closed | -$208K | – | 993 |
|
|
2018
Q3 | $208K | Buy |
+5,600
| New | +$208K | ﹤0.01% | 848 |
|